Canada Life’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-3,863
| Closed | -$208K | – | 2776 |
|
|
2018
Q4 | $208K | Buy |
3,863
+1,252
| +48% | +$68K | ﹤0.01% | 1928 |
|
|
2018
Q3 | $121K | Hold |
2,611
| – | – | ﹤0.01% | 2134 |
|
|
2018
Q2 | $126K | Hold |
2,611
| – | – | ﹤0.01% | 2117 |
|
|
2018
Q1 | $113K | Hold |
2,611
| – | – | ﹤0.01% | 2133 |
|
|
2017
Q4 | $103K | Hold |
2,611
| – | – | ﹤0.01% | 2163 |
|
|
2017
Q3 | $113K | Hold |
2,611
| – | – | ﹤0.01% | 2114 |
|
|
2017
Q2 | $124K | Hold |
2,611
| – | – | ﹤0.01% | 2053 |
|
|
2017
Q1 | $107K | Hold |
2,611
| – | – | ﹤0.01% | 2100 |
|
|
2016
Q4 | $101K | Hold |
2,611
| – | – | ﹤0.01% | 2113 |
|
|
2016
Q3 | $140K | Hold |
2,611
| – | – | ﹤0.01% | 2010 |
|
|
2016
Q2 | $112K | Hold |
2,611
| – | – | ﹤0.01% | 2063 |
|
|
2016
Q1 | $132K | Hold |
2,611
| – | – | ﹤0.01% | 1590 |
|
|
2015
Q4 | $165K | Hold |
2,611
| – | – | ﹤0.01% | 1402 |
|
|
2015
Q3 | $171K | Hold |
2,611
| – | – | ﹤0.01% | 1346 |
|
|
2015
Q2 | $176K | Buy |
2,611
+1,039
| +66% | +$57.3K | ﹤0.01% | 1448 |
|
|
2015
Q1 | $67K | Hold |
1,572
| – | – | ﹤0.01% | 2011 |
|
|
2014
Q4 | $78K | Sell |
1,572
-2,200
| -58% | -$88.1K | ﹤0.01% | 1902 |
|
|
2014
Q3 | $109K | Buy |
+3,772
| New | +$102K | ﹤0.01% | 1619 |
|
Canada Life's IMPV Position: Q1 2019 in Review
Canada Life sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 3,863 shares — an estimated $208K sold.
Canada Life first reported a position in IMPV in Q3 2014 and held it in 18 quarters. The position peaked at $208K in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.
- Canada Life reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
- Canada Life sold 3,863 Imperva, Inc. shares in Q1 2019, an estimated $208K.
- Canada Life first reported a position in Imperva, Inc. in Q3 2014 and held it in 18 quarters.
- Canada Life's Imperva, Inc. position peaked at $208K in Q4 2018.
- 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.
Based on Canada Life's 13F filing for Q1 2019, filed 8 May 2019.